Search Results - "Leweke, F. Markus"

Refine Results
  1. 1

    Cannabis use and psychosis: a review of reviews by Hasan, Alkomiet, von Keller, Rupert, Friemel, Chris Maria, Hall, Wayne, Schneider, Miriam, Koethe, Dagmar, Leweke, F. Markus, Strube, Wolfgang, Hoch, Eva

    “…We conducted a systematic review of meta-analyses and systematic reviews to evaluate the impact of cannabis use on the onset and course of psychoses. Following…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Anandamide dysfunction in prodromal and established psychosis by Leweke, F Markus

    Published in Current pharmaceutical design (01-11-2012)
    “…There is epidemiological evidence that frequent cannabis use in general and during puberty in particular increases the risk to suffer psychosis and psychotic…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia by Severance, Emily G, Gressitt, Kristin L, Stallings, Cassie R, Origoni, Andrea E, Khushalani, Sunil, Leweke, F. Markus, Dickerson, Faith B, Yolken, Robert H

    Published in Schizophrenia research (01-08-2013)
    “…Abstract The origin of inflammation in psychiatric disorders is not well understood. The translocation of commensal microbiota across the gastrointestinal…”
    Get full text
    Journal Article
  6. 6

    Obituary for Professor Hinderk Meiners Emrich, MD PhD by Leweke, F. Markus, Bleich, Stefan, Schneider, Udo

    “…On 16 September 2018 Professor Hinderk Meiners Emrich, MD PhD, Emeritus Director of the Department of Psychiatry, Social Psychiatry and Psychotherapy of…”
    Get full text
    Journal Article
  7. 7

    Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial by Leweke, F Markus, Rohleder, Cathrin, Gerth, Christoph W, Hellmich, Martin, Pukrop, Ralf, Koethe, Dagmar

    Published in Frontiers in pharmacology (29-04-2021)
    “…Cannabidiol (CBD), a principal phytocannabinoid constituent, has demonstrated antipsychotic properties in recent clinical trials. While it has also been…”
    Get full text
    Journal Article
  8. 8

    Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention by Leweke, F. Markus, Mueller, Juliane K., Lange, Bettina, Fritze, Stefan, Topor, Cristina E., Koethe, Dagmar, Rohleder, Cathrin

    Published in CNS drugs (01-07-2018)
    “…The term schizophrenia describes a group of multifaceted psychiatric conditions causing significant impairment of the quality of life of affected patients…”
    Get full text
    Journal Article
  9. 9

    Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state by Koethe, Dagmar, Rohleder, Cathrin, Kracht, Lutz, Leweke, F Markus

    Published in Frontiers in psychiatry (03-03-2023)
    “…Adolescent individuals often present with subtle, sub-threshold psychiatric syndromes that fluctuate or persist for years. These symptoms have been classified…”
    Get full text
    Journal Article
  10. 10

    Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review by Couttas, Timothy A., Jieu, Beverly, Rohleder, Cathrin, Leweke, F. Markus

    Published in Frontiers in psychiatry (27-05-2022)
    “…Schizophrenia spectrum disorders (SSD) are traditionally diagnosed and categorized through clinical assessment, owing to their complex heterogeneity and an…”
    Get full text
    Journal Article
  11. 11

    Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia by Sun, Limin, Castellanos, Nazareth, Grützner, Christine, Koethe, Dagmar, Rivolta, Davide, Wibral, Michael, Kranaster, Laura, Singer, Wolf, Leweke, Markus F, Uhlhaas, Peter J

    Published in Schizophrenia research (01-11-2013)
    “…Abstract Introduction High-frequency oscillations are important for sensory processing and dysfunctions in the amplitude and synchrony of beta- and gamma-band…”
    Get full text
    Journal Article
  12. 12

    Different pharmaceutical preparations of Δ9‐tetrahydrocannabinol differentially affect its behavioral effects in rats by Rohleder, Cathrin, Pahlisch, Franziska, Graf, Rudolf, Endepols, Heike, Leweke, F. Markus

    Published in Addiction biology (01-05-2020)
    “…Based on the contribution of the endocannabinoid system to the pathophysiology of schizophrenia, the primary pro‐psychotic ingredient of Cannabis sativa,…”
    Get full text
    Journal Article
  13. 13

    ReTimeML: a retention time predictor that supports the LC–MS/MS analysis of sphingolipids by Allwright, Michael, Guennewig, Boris, Hoffmann, Anna E., Rohleder, Cathrin, Jieu, Beverly, Chung, Long H., Jiang, Yingxin C., Lemos Wimmer, Bruno F., Qi, Yanfei, Don, Anthony S., Leweke, F. Markus, Couttas, Timothy A.

    Published in Scientific reports (22-02-2024)
    “…The analysis of ceramide (Cer) and sphingomyelin (SM) lipid species using liquid chromatography–tandem mass spectrometry (LC–MS/MS) continues to present…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Distinct molecular phenotypes in male and female schizophrenia patients by Ramsey, Jordan M, Schwarz, Emanuel, Guest, Paul C, van Beveren, Nico J M, Leweke, F Markus, Rothermundt, Matthias, Bogerts, Bernhard, Steiner, Johann, Bahn, Sabine

    Published in PloS one (11-11-2013)
    “…In schizophrenia, sex specific dimorphisms related to age of onset, course of illness and response to antipsychotic treatment may be mirrored by sex-related…”
    Get full text
    Journal Article
  16. 16

    Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers by Bien, Christian G, Rohleder, Cathrin, Mueller, Juliane K, Bien, Corinna I, Koethe, Dagmar, Leweke, F Markus

    Published in Frontiers in psychiatry (26-03-2021)
    “…The pathophysiological role of neural autoantibodies in acute psychotic disorders is receiving increased attention. However, there is still an ongoing debate,…”
    Get full text
    Journal Article
  17. 17

    Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients by Rohleder, Cathrin, Koethe, Dagmar, Fritze, Stefan, Topor, Cristina E., Leweke, F. Markus, Hirjak, Dusan

    “…Objectives Binocular depth inversion illusion (BDII), a visual, ‘top–down’-driven information process, is impaired in schizophrenia and particularly in its…”
    Get full text
    Journal Article
  18. 18

    The Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats by Rohleder, Cathrin, Wiedermann, Dirk, Neumaier, Bernd, Drzezga, Alexander, Timmermann, Lars, Graf, Rudolf, Leweke, F Markus, Endepols, Heike

    Published in Frontiers in behavioral neuroscience (21-07-2016)
    “…Prepulse inhibition (PPI) is a neuropsychological process during which a weak sensory stimulus ("prepulse") attenuates the motor response ("startle reaction")…”
    Get full text
    Journal Article
  19. 19

    Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis by Koethe, Dagmar, Giuffrida, Andrea, Schreiber, Daniela, Hellmich, Martin, Schultze-Lutter, Frauke, Ruhrmann, Stefan, Klosterkötter, Joachim, Piomelli, Daniele, Leweke, F. Markus

    Published in British journal of psychiatry (01-04-2009)
    “…Anandamide is a bioactive lipid binding to cannabinoid receptors. A homeostatic role for anandamide has been suggested in schizophrenia. We investigated its…”
    Get full text
    Journal Article
  20. 20

    Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms by GIUFFRIDA, Andrea, LEWEKE, F. Markus, GERTH, Christoph W, SCHREOBER, Daniela, KOETHE, Dagmar, FAULHABER, Johannes, KLOSTERKÖTTER, Joachim, PIOMELLI, Daniele

    Published in Neuropsychopharmacology (01-11-2004)
    “…The endocannabinoids are a family of bioactive lipids that activate CB1 cannabinoid receptors in the brain and exert intense emotional and cognitive effects…”
    Get full text
    Journal Article